This is not the most recent version of the article. View current version (28 MAY 2014)

Intervention Review

Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients

  1. June D Cody1,*,
  2. Conal Daly2,
  3. Marion K Campbell3,
  4. Cam Donaldson4,
  5. Izhar Khan5,
  6. Luke Vale6,
  7. Sheila A Wallace7,
  8. Alison M MacLeod5

Editorial Group: Cochrane Renal Group

Published Online: 20 JUL 2005

Assessed as up-to-date: 24 MAY 2005

DOI: 10.1002/14651858.CD003895.pub2


How to Cite

Cody JD, Daly C, Campbell MK, Donaldson C, Khan I, Vale L, Wallace SA, MacLeod AM. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003895. DOI: 10.1002/14651858.CD003895.pub2.

Author Information

  1. 1

    University of Aberdeen, Cochrane Incontinence Review Group, Foresterhill, Aberdeen, UK

  2. 2

    Western Infirmary Glasgow, Renal Unit, Glasgow, Scotland, UK

  3. 3

    University of Aberdeen, Health Services Research Unit, Aberdeen, Scotland, UK

  4. 4

    University of Newcastle upon Tyne, Department of Economics, Newcastle upon Tyne, UK

  5. 5

    University of Aberdeen, Department of Medicine and Therapeutics, Aberdeen, UK

  6. 6

    University of Aberdeen, Health Economics, Aberdeen, UK

  7. 7

    University of Aberdeen, Academic Urology Unit, Aberdeen, Scotland, UK

*June D Cody, Cochrane Incontinence Review Group, University of Aberdeen, 1st Floor, Health Sciences Building, Foresterhill, Aberdeen, AB25 2ZD, UK. j.cody@abdn.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JUL 2005

SEARCH

This is not the most recent version of the article. View current version (28 MAY 2014)

  1. You have free access to this content

Previous versions of this article and their online publication dates

  1. Version 2

    Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients

    June D Cody, Conal Daly, Marion K Campbell, Cam Donaldson, Izhar Khan, Luke Vale, Sheila A Wallace and Alison M MacLeod

    Version of Record online: 20 JUL 2005 | DOI: 10.1002/14651858.CD003895.pub2

  2. Version 1

    Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients

    J Cody, C Daly, M Campbell, C Donaldson, A Grant, I Khan, L Vale, S Wallace and A MacLeod

    Version of Record online: 22 APR 2002 | DOI: 10.1002/14651858.CD003895